Search

everythinglearnresearchcommunity

for

Search:↓

Multimedia education greatly improves women's knowledge and management of PCOS.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

PCOS requires personalized treatment to improve life quality and reduce health risks.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.